SummaryDiabetic *Csf1*^*op/op*^ mice do not develop delayed gastric emptying but wild-type *Csf1*^+/+^ mice do. This result reinforces the concept that macrophages are necessary for the development of delayed gastric emptying.

Gastroparesis is a complication of diabetes defined by delayed emptying of stomach contents in the absence of obstruction and is frequently accompanied by early satiety, nausea, vomiting, and pain.[@bib1], [@bib2], [@bib3] Recent publications have highlighted the cellular changes associated with gastroparesis in humans[@bib4], [@bib5] and in mouse models of the disease.[@bib6], [@bib7] These include changes to interstitial cells of Cajal (ICC), extrinsic and enteric nerves and smooth muscle cells.[@bib8] The development of delayed gastric emptying (GE) is associated with reduced expression of the receptor tyrosine kinase, Kit, a marker for interstitial cells of Cajal,[@bib6] impairment of ICC networks and changes in the electrical slow wave recorded from smooth muscle cells.[@bib5], [@bib9]

Macrophages originate from monocytes, play a critical role in innate immunity and also participate in adaptive immunity.[@bib10], [@bib11] Release of cytokines from polarized macrophages can both increase inflammation as well as play important anti-inflammatory roles.[@bib10] Resident macrophages are present in the muscle layers of the gastrointestinal tract.[@bib12], [@bib13] They can be polarized in response to changes in the microenvironment. Polarized macrophages in mice may be classified in two main groups: the proinflammatory, classically activated macrophages (M1) and anti-inflammatory, alternatively activated macrophages (M2).[@bib11] Polarization results in a change in their phenotype and their physiology, including alterations in the expression of surface proteins and the production of specific cytokines.[@bib10], [@bib11]

Macrophages appear to play an important role in the development of delayed GE in both diabetic mice and humans. CD206 positive M2 macrophages expressing heme oxygenase 1 (HO1) are critical to the prevention of development of delayed GE in diabetic mice and induction of HO1 in macrophages leads to reversal of the delay in GE.[@bib6] In humans the number of CD206-positive M2 macrophages correlates with the number of ICC which in turn correlates with GE.[@bib14] The exact role of macrophages in the development of delayed GE during diabetes is still not known. For example, it remains unclear whether it is the presence of a particular subtype (ie, M1 macrophages) versus the absence of a subtype (ie, M2 macrophages) that leads to development of delay in GE.

Mice homozygous for the naturally occurring *Csf1*^*op*^ (osteopetrosis, *op*) gene mutation lack functional macrophage-colony stimulating factor (Csf1, also known as MCSF or Csfm)[@bib15] and are deficient in Csf1-dependent macrophages. Because previous studies have shown the absence of macrophages from the muscle layers of the small intestine of *Csf1*^*op/op*^ mice,[@bib12] they offer the opportunity to understand the role of macrophages in the development of GE in diabetes.

Materials and Methods {#sec1}
=====================

Experiments were performed in accordance with the National Institutes of Health *Guide for the Care and Use of Laboratory Animals*. All protocols were approved by the Institutional Animal Care and Use Committee of the Mayo Clinic.

Animals and in Vivo Experimentation {#sec1.1}
-----------------------------------

The experimental plan is summarized in [Figure 1](#fig1){ref-type="fig"}. Mice heterozygous for a loss of function mutation in the Csf1 gene were obtained from the Jackson Laboratory (Bar Harbor, ME; strain: B6; C3Fe a/a-Csf1^op^/J, cat. no. 000231). The osteopetrosis (*Csf1*^*op*^) mutation is a single base pair insertion in the coding region of the *Csf1* gene that generates a stop codon 21 base pair downstream of the insertion.[@bib15] Detection of wild-type (WT) *Csf1*^*+/+*^ and heterozygous animals by Sanger sequencing of polymerase chain reaction (PCR) products was performed by Laragen (Culver City, CA). Homozygous *Csf1*^*op/op*^ mice were distinguished from their normal littermates phenotypically at 10--15 days of age by the absence of incisor eruption. Due to the lack of teeth, *Csf1*^*op/op*^ pups were started on a liquid diet at 3--4 weeks of age and were weaned from the mother at 5--6 weeks of age. These mice were maintained until they were up to 6 months old by the use of a specialized wet diet (Bio-Serv, Frenchtown, NJ).

WT *Csf1*^*+/+*^ and *Csf1*^*op/op*^ mice were treated with a single injection of streptozotocin (160 mg/kg) at 12 weeks of age to make them diabetic. The mice that did not become diabetic after 1 week received up to two further injections of streptozotocin spaced a week apart. Using this regimen, all WT *Csf1*^*+/+*^ mice became diabetic (defined as blood glucose \>250 mg/dL). Mice weighing less than 20 g at 12 weeks old were not used in this study. Starting 4 days after induction, blood glucose levels were measured daily. Subtherapeutic insulin (Lantus insulin glargine; Sanofi-Aventis U.S., Bridgewater, NJ) was injected once a day intraperitoneally when the glucose levels were over 500 mg/dL to keep the diabetic mice alive and but to still keep blood glucose levels between 400 and 600 mg/dL in order for complications of diabetes to develop. Oxidative stress was measured by determining malondialdehyde (MDA) levels in the plasma as previously described elsewhere[@bib6] using a commercial kit to detect thiobarbituric acid reactive substances (Oxi-Tek; Zeptometrix, Buffalo, NY).

Gastric emptying of solids (cooked egg yolk) was measured after an overnight fast using a ^13^\[C\]-octanoic acid breath test as described previously elsewhere.[@bib16] *Csf1*^*op/op*^ mice required more training than WT *Csf1*^*+/+*^ mice due to their lack of teeth. However, by preparing the egg meal to be a soft consistency, the majority of animals could be trained to eat it within 5 minutes of being offered the meal. Because *Csf1*^*op/op*^ mice do not have teeth, they were fed with less scrambled cooked egg yolk (100 mg) than used for the *Csf1*^*+/+*^ mice (200 mg). If the mice did not eat \>50% of the egg meal after 3 weeks of training, they were removed from the study. Four baseline values for GE half-time (*t*~1/2~) were obtained before the delivery of streptozotocin. After the onset of diabetes, GE was measured weekly.

Dissection of Tissue {#sec1.2}
--------------------

The mice were killed with an overdose of carbon dioxide. The stomach was cut along the lesser curvature, and the mucosal layer was removed by sharp dissection from the smooth muscle layer of the body and antrum for experiments.

Immunohistochemistry {#sec1.3}
--------------------

The antibodies used were a rat monoclonal raised against the mouse F4/80 epitope conjugated to Alexa Fluor 488 (cat. no. MF48020; Life Technologies, Grand Island, NY), and a rat monoclonal raised against mouse Kit, ACK2 (cat. no. 14-1172-85; eBioscience, San Diego, CA). The immunohistochemical procedures used for each cell type are summarized herein.

Macrophages {#sec1.4}
-----------

Macrophages were identified using a modification of a previously published fluorescence immunolabeling technique.[@bib7] Freshly dissected tissues were incubated in F4/80 antibody Alexa Fluor 488 conjugate diluted to 0.4 μg/mL with Ca^2+^-containing HEPES-buffered physiologic salt solution containing 135 mM NaCl, 5 mM KCl, 2 mM CaCl~2~, 1.2 mM MgCl~2~, 10 mM glucose, and 10 mM HEPES, adjusted to pH 7.4 with Tris and incubated at 37°C for 1 hour in the dark. The tissue was then fixed in 4% paraformaldehyde in 0.1 M phosphate buffer. After the tissue was rinsed in 0.1 M phosphate-buffered saline (PBS) then water, the nuclei in the tissue were stained by incubating the tissue for 30 minutes at 4°C with 0.3 μM 4′6-diamidino-2-phenylindole dihydrochloride (DAPI) (Molecular Probes, Eugene, OR) in water.

Interstitial Cells of Cajal {#sec1.5}
---------------------------

After fixation by immersion in cold acetone for 15 minutes, ICC were detected by use of an anti-Kit antibody (ACK2). The tissue was washed three times in 0.1 M PBS then blocked in 10% normal donkey serum (NDS) in PBS and 0.3% Triton overnight at 4°C. The Kit antibody (1.7 μg/mL) was applied by incubation in 5% NDS/PBS/0.3% Triton for 2 days at 4°C. After rinsing in PBS, donkey anti-rat IgG conjugated to fluorescein (3 μg/mL; Chemicon, Temecula, CA) was added in 2.5% NDS/PBS/0.3% Triton and incubated overnight at 4°C in the dark. After rinsing in PBS then water, nuclei in the tissue were stained by incubating the tissue for 30 minutes at 4°C with 0.3 μM 4′6-diamidino-2-phenylindole dihydrochloride (DAPI) in water.

Confocal Microscopy for Kit-Positive Interstitial Cells of Cajal and Assessment and Quantification of Kit Immunoreactivity {#sec1.6}
--------------------------------------------------------------------------------------------------------------------------

Labeled tissues were examined with a laser scanning confocal microscope using a 20× (NA 0.95) XLUMPlanFl objective (Olympus Japan) in Fluoview (Olympus Japan) using the optimal confocal aperture to give a resolution of 0.994 × 0.994 × 1.13 μm (*X* × *Y* × *Z*). Stacks of confocal images across the full thickness of the muscularis propria were collected from three nondiabetic *Csf1*^*op/op*^ mice (20--22 weeks old), three diabetic *Csf1*^*op/op*^ mice (20--22 weeks old), three nondiabetic *Csf1*^*+/+*^ mice (20--22 weeks old), and three diabetic *Csf1*^*+/+*^ with normal GE and 3 diabetic *Csf1*^*+/+*^ with delayed GE mice (2, 3, and 4.6 weeks after onset of diabetes). Six images from the gastric body and three from the antrum were taken for each animal. For quantification of the labeling, all of the confocal image stacks were flattened into projections using the FV10-ASW Viewer (Olympus). The flattened images were renumbered in random order and then assessed by scoring the integrity of the ICC on a 10-cm visual analogue scale for network density. Scoring was done in random order by two independent investigators blind to the image and tissue source.

Real-Time Quantitative Reverse-Transcription Polymerase Chain Reaction {#sec1.7}
----------------------------------------------------------------------

RNA extracted from gastric muscularis propria of *Csf1*^*op/op*^ and wild-type *Csf1*^+/+^ mice were used for this real-time quantitative reverse-transcription polymerase chain reaction (qRT-PCR). RNA extraction was done with RecoverAll (Ambion, Austin, TX) according to the manufacturer's instructions. The SuperScript VILO cDNA Synthesis Kit (Invitrogen, Carlsbad, CA) was used to generate cDNA from extracted RNA and qRT-PCR was performed on cDNA using commercial primer sets and RT2SYBR Green/ROX qRT-PCR master mix according to the manufacturer\'s instructions (SABiosciences, Frederick, MD). The data were normalized to the expression of actin, a housekeeping gene, by transforming the difference in threshold cycle (ΔCt) to the ratio of the gene of interest to the housekeeping gene (2^−ΔCt^),[@bib17] and expressed as the mean ± standard error of the mean (SEM) for six animals of each group.

Statistical Analysis {#sec1.8}
--------------------

The statistical methods used were unpaired *t* tests and one-way analysis of variance (ANOVA) with post-test adjustments for multiple comparisons. *P* \< .05 was considered statistically significant. All authors had access to the study data and reviewed and approved the final manuscript.

Results {#sec2}
=======

The gastric muscularis propria of WT *Csf1*^*+/+*^ mice was densely populated with macrophages as detected by F4/80 immunoreactivity ([Figure 2](#fig2){ref-type="fig"}*A*). These cells had a characteristic morphology with several flattened pseudopodia that branched from the main axis of the cell. However, no F4/80-positive macrophages were found in the muscle layers from the stomach of *Csf1*^*op/op*^ mice before or after the development of diabetes (see [Figure 2](#fig2){ref-type="fig"}*B* and *C*). Before the development of diabetes, the *Csf1*^*op/op*^ mice were smaller in size when compared with the WT *Csf1*^*+/+*^ mice (see [Figure 2](#fig2){ref-type="fig"}*D*; WT 25.11 ± 3.72, Op/Op 21.92 ± 2.23 g; *P* \< .05, unpaired *t* test).

The blood glucose values in nondiabetic mice did not differ between the groups ([Figure 3](#fig3){ref-type="fig"}*A*; WT 117 ± 16, Op/Op 106 ± 18 mg/dL; *P* = not statistically significant \[NS\], one-way ANOVA with Tukey's post-test). After treatment with streptozotocin to induce diabetes, the diabetic mice had similar elevated nonfasting blood glucose levels regardless of whether they were WT *Csf1*^+/+^ or *Csf1*^*op/op*^ (see [Figure 3](#fig3){ref-type="fig"}*A*; WT 410.89 ± 62.79, Op/Op 342.15 ± 67.94; *P* = NS, one-way ANOVA with Tukey's post-test). Both groups of mice received similar levels of insulin to maintain blood glucose \<600 mg/dL after the onset of diabetes (WT 3.98 ± 0.57, Op/Op 5.77 ± 1.55 unit/week; *P* = NS, *t* test).

Normal GE values for *Csf1*^*op/op*^ mice had not been previously reported, so we determined the normal ranges for GE times in *Csf1*^*op/op*^ and WT *Csf*1^+/+^ mice in separate cohorts. The normal range was defined as between the 2.5th and 97.5th percentiles (see [Figure 3](#fig3){ref-type="fig"}*B*; WT dashed lines, 53--119 minutes, median 80 minutes, n = 9; *Csf1*^*op/op*^ solid lines, 34--96 minutes, median 63, n = 15). In the nondiabetic mice in this study, the *t*~1/2~ values (mean ± SEM) for GE were statistically significantly lower in *Csf1*^*op/op*^ mice compared with WT (see [Figure 3](#fig3){ref-type="fig"}*B*; WT 86 ± 4.5 minutes, n = 10; Op/Op 66.77 ± 5.37 minutes, n = 15; *P* \< .05, one-way ANOVA with Tukey's post-test). Despite severe diabetes, in *Csf1*^*op/op*^ mice the GE values remained in the normal range for up to 8 weeks after induction of diabetes and were not statistically significantly different from the values obtained before diabetes (see [Figure 3](#fig3){ref-type="fig"}*B*, op/op nondiabetic 66.77 ± 3.42; op/op diabetic: 62.12 ± 1.82 minutes, *P* = NS, one-way ANOVA with Tukey's post-test). In distinct contrast, 4 out of 13 WT mice developed delayed GE at a mean of 6.25 ± 2.5 weeks after induction of diabetes as indicated by readings outside the normal range (dashed lines) for WT nondiabetic mice (see [Figure 3](#fig3){ref-type="fig"}*B*). This was statistically significantly different from the observation that no *Csf1*^*op/op*^ mice had delayed GE over the same period (*P* = .03, Fisher's exact test), similar to the percentage of diabetic, nonobese diabetic (NOD) mice that developed delayed GE in our previous studies.[@bib6] Diabetic WT *Csf*1^+/+^ mice with delayed GE had longer *t*~1/2~ values than the nondelayed diabetic WT *Csf*1^+/+^, nondiabetic WT *Csf1*^+/+^, and both diabetic and nondiabetic *Csf1*^*op/op*^ mice (see [Figure 3](#fig3){ref-type="fig"}*B*, WT diabetic with delayed GE; 154.9 ± 12.17 minutes; *P* \< .05, one-way ANOVA with Tukey's post-test). These data are consistent with an absence of macrophages resulting in resistance to development of delayed GE in the cohort studied.

Previous work using NOD mice showed that oxidative stress is elevated in diabetic NOD mice and further elevated in diabetic NOD mice with delayed GE.[@bib6] MDA levels greater than 80 nmol/mL were invariably associated with delayed GE.[@bib6] In nondiabetic mice the levels of oxidative stress as measured by plasma MDA levels (mean ± SEM) were not different between *Csf1*^*op/op*^ mice and WT *Csf1*^*+/+*^ littermates ([Figure 4](#fig4){ref-type="fig"}; WT nondiabetic 4.34 ± 1.30, Op/Op nondiabetic 10.03 ± 5.11 nmol/mL; n = 5, *P* = NS, one-way ANOVA with Tukey's post-test). After the onset of diabetes MDA levels were statistically significantly elevated in the *Csf1*^*op/op*^ compared with the *Csf1*^*+/+*^ littermates (see [Figure 4](#fig4){ref-type="fig"}; *Op/Op* diabetic with normal GE 75.8 ± 9.1 nmol/mL, WT diabetic with normal GE 41.2 ± 13.6; n = 5, *P* \< .05, one-way ANOVA with Tukey's post-test). As previously reported for NOD mice, development of delayed GE in WT, *Csf1*^*+/+*^ was accompanied by increased levels of MDA (see [Figure 4](#fig4){ref-type="fig"}; WT diabetic with delayed GE 102.5 ± 9.19 nmol/mL; n = 5, *P* \< .05, one-way ANOVA with Tukey's post-test). Despite diabetic *Csf1*^*op/op*^ mice all having normal GE, the MDA levels were as high as those found in diabetic WT *Csf1*^*+/+*^ mice with delayed GE (see [Figure 4](#fig4){ref-type="fig"}; n = 5, *P* = NS, one-way ANOVA with Tukey's post-test).

Reduced Kit expression and impairment of ICC networks in gastric muscularis propria are associated with development of delayed GE and impairment of ICC networks in diabetic mice.[@bib6] We measured the Kit mRNA levels by qRT-PCR in gastric muscularis propria ([Figure 5](#fig5){ref-type="fig"}). Although there was statistically significant variation in the levels of Kit mRNA from the tissues, there was no statistically significant difference in the Kit mRNA levels between *Csf1*^*op/op*^ and WT mice with normal GE whether diabetic or not diabetic (see [Figure 5](#fig5){ref-type="fig"}; WT nondiabetic 2.16 ± 0.87, Op/Op nondiabetic 4.23 ± 2.45 fold change over actin; n = 5, *P* = NS, one-way ANOVA with Tukey post-test). Diabetic WT *Csf1*^*+/+*^ mice with delayed GE had statistically significantly lower expression of Kit mRNA compared with diabetic WT *Csf1*^*+/+*^ mice with normal GE (*P* = .03, *t* test), but this was not statistically significant for multiple comparisons (see [Figure 5](#fig5){ref-type="fig"}; WT diabetic 2.12 ± 0.76; WT diabetic with delayed GE 1.01 ± 0.19, fold change; n = 5, *P* = NS, one-way ANOVA with Tukey post-test).

Damage to ICC networks is a common observation in mice and humans with delayed GE.[@bib5], [@bib6], [@bib9] To determine whether diabetic *Csf1*^*op/op*^ mice had disrupted ICC networks even though GE was normal, we immunolabeled tissues for Kit and examined the ICC networks. There was no difference in density of Kit-positive ICC between gastric muscularis propria tissues from nondiabetic *Csf1*^*op/op*^ mice ([Figure 6](#fig6){ref-type="fig"}*B*) and tissues from *Csf1*^*op/op*^ mice that had been diabetic for more than 8 weeks (see [Figure 6](#fig6){ref-type="fig"}*D*), as scored by two independent, blinded investigators (see [Figure 6](#fig6){ref-type="fig"}*F*; Op/Op nondiabetic 6.06 ± 0.37, Op/Op diabetic 6.98 ± 0.14 density; n = 5, *P* = NS, one-way ANOVA with Dunnett's post-test). No differences were also observed in ICC density between the nondiabetic *Csf1*^*op/op*^ mice (see [Figure 6](#fig6){ref-type="fig"}*B*) and the nondiabetic WT (see [Figure 6](#fig6){ref-type="fig"}A) *Csf1*^*+/+*^ (see [Figure 6](#fig6){ref-type="fig"}*F*; WT nondiabetic 6.61 ± 0.32; n = 5, *P* = NS, one-way ANOVA with Dunnett's post-test). However diabetic *Csf1*^*+/+*^ mice that developed delayed GE (see [Figure 6](#fig6){ref-type="fig"}*E*) had reduced ICC density when compared with the diabetic *Csf1*^*+/+*^ with normal GE (see [Figure 6](#fig6){ref-type="fig"}*D* and *F*; WT diabetic with delayed GE 5.71 ± 0.17, WT diabetic with normal GE 6.81 ± 0.04 density; n = 5, *P* \< .005, one-way ANOVA with Dunnett's post-test).

Discussion {#sec3}
==========

Our main and surprising finding was that diabetic *Csf1*^*op/op*^ mice do not develop delayed GE while their WT siblings do. This suggests that macrophages are required for the development of delayed GE in diabetes. We performed this study because we previously had reported that HO1-expressing, CD206-positive, alternatively activated macrophages protected diabetic NOD mice from development of delayed GE^7^ and that numbers of CD206-positive macrophages correlate with ICC numbers in humans with diabetic gastroparesis.[@bib14] We thus hypothesized that depletion of macrophages---including, of course, M2 macrophages---would lead to higher rates of delayed GE in diabetic mice. Our findings support an alternative hypothesis that although M2 macrophages can protect gastric cell types from injury, macrophages---likely M1 macrophages releasing injurious proinflammatory cytokines---are required to damage these key cell types, including ICC.

The protection of the diabetic *Csf1*^*op/op*^ mice against developing delayed GE occurred despite levels of oxidative stress, elevated blood glucose, and dosing with insulin that were not different from the WT siblings used in this study. We also found that changes associated with delayed GE in diabetic mice[@bib6] and humans,[@bib5], [@bib14] namely, disruption of ICC networks and reduced expression of Kit, were not found in the long-term diabetic *Csf1*^*op/op*^ mice. Thus, it appears that mechanisms that result in development of delayed GE in diabetic mice on the time scale we studied are mediated through a population of macrophages that are dependent on Csf1 signaling. However this requires confirmation by testing the effect of populating the gastric muscularis propria of diabetic *Csf1*^*op/op*^ mice with macrophages.

We used *Csf1*^*op/op*^ mice as we could not produce long-term depletion of macrophages in diabetic mice either by using clodronate liposomes as described by Van Rooijen et al[@bib18] or by treating with diphtheria toxin in mice that specifically express the diphtheria toxin receptor on CD11b-positive macrophages.[@bib19] We found that clodronate liposomes did not cause a sustained loss of macrophages, which was required for our experiments, and the mice treated with diphtheria toxin all died within 4 weeks (data not shown).

The *Csf1*^*op/op*^ mouse does not express macrophages in the lamina propria or the muscularis propria of the small intestine,[@bib11], [@bib20] and we found that it does not express gastric macrophages even when made diabetic. *Csf1*^*op/op*^ mice have significant developmental problems that include failure to develop teeth, skeletal abnormalities, and lower levels of blood monocytes. Moreover, as elsewhere reported, they are smaller in size when compared with age-matched WT littermates. Despite this, with careful handling, the mice survived the induction of diabetes and survived to the end of the 8 weeks of diabetes.

The *Csf1*^*op/op*^ mice had low levels of plasma MDA comparable with the WT *Csf1*^*+/+*^ littermates before induction of diabetes and had significantly higher levels after the onset of diabetes. This is an observation that has not been previously reported. Our study indicates that high oxidative stress as indicated by oxidation of lipids and elevated MDA levels is not sufficient to cause cellular injury without macrophages.

A recent study[@bib21] has highlighted a role of resident macrophages in regulating intestinal contractility through an interaction with the enteric nervous system and the intestinal microbiome. It therefore appears that both resident and activated macrophages have previously unknown roles in modulating gastrointestinal motor function separate from their known role in immunity. WT *Csf1*^*+/+*^ mice behaved as observed in other studies on NOD, C57Bl6, and BALB/c mice (unpublished data)[@bib6], [@bib16] in that diabetic gastroparesis was associated with higher levels of oxidative stress and that decreased Kit expression is found in the diabetic mice that develop delayed GE. The time course for development of delayed GE (6.25 weeks after onset of diabetes) was similar to that found in NOD mice (5.5 weeks).[@bib6] Thus, it appears that the streptozotocin-induced diabetic mouse model is useful for studying mechanisms that might underlie diabetic gastroparesis. *Csf1*^*op/op*^ mice did have slightly but significantly faster GE than WT siblings before and after induction of diabetes due to the inability of these animals to eat the full 0.2 g meal. However, a consequence of the faster GE in *Csf1*^*op/op*^ mice was that the upper threshold for normal GE was lower in mice after induction of diabetes compared with WT mice but even that lower threshold was not crossed with onset of diabetes. Thus, *Csf1*^*op/op*^ mice represent a strain of mice that can be exploited to further investigate the role of macrophages in diabetes-induced tissue injury.

Our data strongly suggest that development of delayed GE in diabetes requires the presence of muscle-layer macrophages and that known mechanisms of injury in diabetes appear to converge on macrophages. In particular, M2 macrophages can protect gastric cells from injury, and M1 macrophages are required to damage these key cells, including ICC. In fact, despite the absence of M2 macrophages, the absence of injurious M1 cells during diabetes in op/op mice results in no changes in ICC and therefore in the absence of delay. Targeting macrophages may therefore be an effective therapeutic option to prevent cellular damage and the development of delayed GE in diabetes.
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![**Experimental plan used for the different groups of mice.** (*A*) Starting at 8 weeks old, female *Csf1*^*+/+*^ wild-type (WT) mice were trained, and two baseline gastric emptying (GE) readings (*arrows*) were obtained before the mice were treated with streptozotocin starting at 12 weeks (*arrowhead*). Only mice weighing more than 20 g were used. After development of diabetes, when the mice were 12--14 weeks old, GE was measured weekly for up to 8 weeks. Tissues were collected from three groups of *Csf1*^*+/+*^ mice: (1) diabetic mice that develop delayed GE indicated by *t*~1/2~ values outside the normal range on 2 consecutive weeks, (2) mice with normal GE matched to the mice with delayed GE by duration of diabetes, and (3) resistant mice that did not develop delayed GE after 8 weeks of diabetes. (*B*) Sibling *Csf1*^*op/op*^ (Op/Op) mice underwent the same regimen. These mice did not develop delayed GE, and they were killed for tissue and blood collection after 8 weeks of diabetes (20--22 weeks of age). *Csf1*^*op/op*^ (Op/Op) without diabetes were observed for the same period of time and used as controls (20--22 weeks of age).](gr1){#fig1}

![***Csf1*^*op/op*^ mice lack macrophages in the gastric muscularis propria.** (*A*) Resident macrophages in the muscularis propria of wild-type (WT) *Csf1*^*+/+*^ mice. Whole-mount preparations from the murine stomach were labeled with the F4/80 antibody. *Csf1*^*op/op*^ mice lack macrophages in the gastric muscularis propria when (*B*) not diabetic and (*C*) 8 weeks after the development of diabetes. Scale bar: 50 μm for each image. Age of mice: 20--22 weeks. (*D*) Weight of WT *Csf1*^*+/+*^ and *Csf1*^*op/op*^ (Op/Op) mice before the development of diabetes. The circles represent individual animals. *Csf1*^*+/+*^ (WT) were heavier than *Csf1*^*op/op*^ (Op/Op) at the beginning of the experiment. Data are represented as mean ± standard error of the mean. ^a^*P* \< .05, unpaired *t* test. Age of mice: 12--14 weeks.](gr2){#fig2}

![**Glucose levels and gastric emptying status in wild-type (WT) *Csf1***^***+/+***^**and *Csf1***^***op/op***^**(Op/Op) mice before and after induction of diabetes (Db).** Data are represented as mean ± standard error of the mean (SEM) of the grouped data (*P* \< .05, one-way ANOVA with Tukey's post test). The circles represent individual animals. (*A*) As expected, glucose levels were statistically significantly higher in diabetic versus nondiabetic mice, *P* \< .05, n = 5 mice/group. (*B*) Gastric emptying values in the same five groups of mice. The normal ranges for GE times (2.5th to 97.5th percentiles) in nondiabetic mice are shown for WT mice as dotted lines and for Op/Op mice as solid lines. Data are represented as mean ± SEM of the grouped data (*P* \< .001, one-way ANOVA), and circles represent individual animals. Statistical significance (*P* \< .05, Tukey's post test) is indicated by (a) versus nondiabetic WT, (b) versus nondiabetic Op/Op, (c) versus diabetic WT with normal emptying, and (d) versus diabetic Op/Op. Age of mice: 12--14 weeks at the induction of diabetes, 20--22 weeks for diabetic mice with normal GE, 16--22 weeks for diabetic WT mice with delayed GE.](gr3){#fig3}

![**Malondialdehyde levels were significantly higher in diabetic *Csf1***^***op/op***^**(Op/Op) mice compared with diabetic wild-type (WT) *Csf1***^***+/+***^**mice with normal gastric emptying (GE).** Data are expressed as mean ± standard error of the mean (SEM) (n = 5 groups of mice). Malondialdehyde levels were significantly higher in WT with delayed GE (one-way analysis of variance with Tukey's post test). Data are represented as mean ± SEM of the grouped data, and circles represent individual animals. Significance (*P* \< .05) is indicated by (a) versus nondiabetic WT, (b) versus nondiabetic Op/Op, and (c) versus diabetic WT with normal GE (n = 5). Age of mice: 20--22 weeks.](gr4){#fig4}

![***Csf1***^***op/op***^**(Op/Op) and wild type (WT) *Csf1***^***+/+***^**mice express similar levels of Kit mRNA.** Relative Kit expression was statistically significantly lower in diabetic WT *Csf1*^*+/+*^ mice with delayed gastric emptying (GE) compared with diabetic WT *Csf1*^*+/+*^ mice with normal GE (^a^*P* = .03, *t* test), but there were no statistically significant differences when correcting for multiple comparisons (one-way analysis of variance, *P* = NS). Data are mean ± standard error of the mean; n = 5 mice. Age of mice: 20--22 weeks.](gr5){#fig5}

![**Interstitial cells of Cajal (ICC) networks were not affected by diabetes in *Csf1***^***op/op***^**mice while the development of delayed gastric emptying (GE) in diabetic *Csf1***^***+/+***^**was associated with reduced density of ICC.** Images of Kit immunoreactivity in the muscularis propria of the distal corpus of the mouse stomach in nondiabetic *Csf1*^*+/+*^ (*A*) wild type (WT) and *Csf1*^*op/op*^ (*B*) Op/Op; in diabetic *Csf1*^*+/+*^ (*C*) and *Csf1*^*op/op*^ (*D*) with normal GE; and in diabetic *Csf1*^*+/+*^ with delayed GE (*E*) (age-matched/representative of n = 3). Scale bar: 100 μm for each image. Whiskers show the mean ± standard deviation of the scores from biological replicates (n = 3 mice; *P* \< .05, one-way analysis of variance with Dunnett's post test). Each circle represents the overall score from nine regions in each individual animal. Age of mice: 20--22 weeks for diabetic and nondiabetic *Csf1*^*op/op*^ mice; 20--22 weeks for WT control; diabetic Csf1^+/+^ (WT) mice with delayed or normal GE (14--20 weeks old).](gr6){#fig6}
